Cross-disciplinary subjects - page 11 Scientific Publications

Latest publication 11/30/2009

Isobolographic characterization of the anticonvulsant interaction profiles of le

This study was designed so as to characterize the interactions between levetiracetam (LEV) and the conventional antiepileptic drugs (AEDs)...

Array
(
    [id_prestablog_news] => 239
    [id_shop] => 1
    [date] => 2009-11-30 00:00:00
    [date_modification] => 2024-02-09 14:15:11
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 475
    [id_lang] => 1
    [title] => Isobolographic characterization of the anticonvulsant interaction profiles of le
    [paragraph] => Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in combination with clonazepam, ethosuximide, phenobarbital and valproate in the mouse pentylenetetrazole-induced seizure model.
    [content] => 
Authors
M. Dudra-Jastrzebska, M. M. Andres-Mach, N. Ratnaraj, P. N. Patsalos, S. J. Czuczwar.

 Lab
Medical University, Department of Pathophysiology, and Institute of Agricultural Medicine, Department of Physiopathology, Lublin, Poland.
Journal
Seizure
Abstract
This study was designed so as to characterize the interactions between levetiracetam (LEV) and the conventional antiepileptic drugs (AEDs) clonazepam (CZP), ethosuximide (ETS), phenobarbital (PB), and valproate (VPA) in suppressing pentylenetetrazole (PTZ)-induced clonic seizures in mice by use of type II isobolographic analysis. Adverse-effect profiles of the drugs in combination were determined and brain AED concentrations were measured. The combinations of VPA and ETS with LEV at the fixed-ratio of 1:2, CZP with LEV (1:20,000), and PB with LEV (1:20) were supra-additive (synergistic) in suppressing seizures. In contrast, VPA and ETS with LEV (1:1, 2:1, and 4:1), CZP with LEV (1:1000, 1:5000, and 1:10,000), and PB with LEV (1:1, 1:5, and 1:10) were additive. No adverse effects were observed. ETS significantly reduced brain LEV concentrations but no other pharmacokinetic changes were observed. The combinations of CZP with LEV (1:20,000); VPA and ETS with LEV (1:2); and PB with LEV (1:20) appear to be favorable combinations exerting supra-additive interactions in suppressing PTZ-induced seizures.
BIOSEB Instruments Used
Grip strength test (BIO-GS3)
    [meta_description] => 
    [meta_keywords] => http://www.sciencedirect.com/science/article/pii/S1059131109001356
    [meta_title] => 
    [link_rewrite] => isobolographic-characterization-of-the-anticonvulsant-interaction-profiles-of-levetiracetam-in-combination-with-clonazepam--ethosuximide--phenobarbital-and-valproate-in-the-mouse-pentylenetetrazole-induced-seizure-model-
    [actif_langue] => 1
    [read] => 996
    [count_comments] => 0
    [id] => 239
    [categories] => Array
        (
            [11] => Array
                (
                    [id_prestablog_categorie] => 11
                    [title] => Central Nervous System (CNS)
                    [link_rewrite] => Central-Nervous-System-(CNS)
                )

            [24] => Array
                (
                    [id_prestablog_categorie] => 24
                    [title] => Cross-disciplinary subjects 
                    [link_rewrite] => Cross-disciplinary-subjects-
                )

            [41] => Array
                (
                    [id_prestablog_categorie] => 41
                    [title] => Epilepsy
                    [link_rewrite] => Epilepsy
                )

            [95] => Array
                (
                    [id_prestablog_categorie] => 95
                    [title] => Pharmacology
                    [link_rewrite] => Pharmacology
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Isobolographic characterization of the anticonvulsant interaction profiles of levetiracetam in [...]
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [48] => Array
                (
                    [name] => Grip strength test
                    [description_short] => 
An easy way to objectively quantify the muscular strength of mice and rats, and to assess the effect of drugs, toxins, muscular (i.e. myopathy) and neurodegenerative diseases on muscular degeneration. It is widely used in conjunction with the ROTAROD motor coordination test: a normally coordinated rodent will show a decreased latency to fall off the rotating rod if its muscular strength is low. The Grip Strength Test is a must for your research on activity, motor control & coordination, and is particularly well suited for studies on Parkinson's & Huntington's disease.
New features GS4 - 2023: Color display with permanent backlight screen for easier reading, reset by footswitch, Improved battery time, Larger data memory of 500 values, Animal counter, USB port (charging/data transfer)

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/activity-motor-control-coordination/48-grip-strength-test.html
                )

        )

)
1